Literature DB >> 19287053

Animal models of tuberculosis for vaccine development.

U D Gupta1, V M Katoch.   

Abstract

Animal models for testing different vaccine candidates have been developed since a long time for studying tuberculosis. Mice, guinea pigs and rabbits are animals most frequently used. Each model has its own merits for studying human tuberculosis, and none completely mimics the human disease. Different animal models are being used depending upon the availability of the space, trained manpower as well as other resources. Efforts should continue to develop a vaccine which can replace/outperform the presently available vaccine BCG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287053

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  22 in total

1.  Mice continue to be a good model for preliminary assessment of tuberculosis vaccine candidates.

Authors:  Michel de Jesús Aceves-Sánchez; Mario Alberto Flores-Valdez
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

2.  Vaxar: A Web-Based Database of Laboratory Animal Responses to Vaccinations and Its Application in the Meta-Analysis of Different Animal Responses to Tuberculosis Vaccinations.

Authors:  Thomas Todd; Natalie Dunn; Zuoshuang Xiang; Yongqun He
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

3.  Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis.

Authors:  Ajay Grover; Jolynn Troudt; Kimberly Arnett; Linda Izzo; Megan Lucas; Katie Strain; Christine McFarland; Yper Hall; David McMurray; Ann Williams; Karen Dobos; Angelo Izzo
Journal:  Tuberculosis (Edinb)       Date:  2011-10-01       Impact factor: 3.131

4.  Plague in Guinea pigs and its prevention by subunit vaccines.

Authors:  Lauriane E Quenee; Nancy Ciletti; Bryan Berube; Thomas Krausz; Derek Elli; Timothy Hermanas; Olaf Schneewind
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

5.  Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.

Authors:  Jiuling Wang; Yaqing Qie; Wei Liu; Honghai Wang
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

6.  Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice.

Authors:  Zhenhai Chen; Tuhina Gupta; Pei Xu; Shannon Phan; Adrian Pickar; Wilson Yau; Russell K Karls; Frederick D Quinn; Kaori Sakamoto; Biao He
Journal:  Vaccine       Date:  2015-11-06       Impact factor: 3.641

7.  Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis.

Authors:  Joseba M Garrido; Iker A Sevilla; Beatriz Beltrán-Beck; Esmeralda Minguijón; Cristina Ballesteros; Ruth C Galindo; Mariana Boadella; Konstantin P Lyashchenko; Beatriz Romero; Maria Victoria Geijo; Francisco Ruiz-Fons; Alicia Aranaz; Ramón A Juste; Joaquín Vicente; José de la Fuente; Christian Gortázar
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

8.  BCG induces protection against Mycobacterium tuberculosis infection in the Wistar rat model.

Authors:  Amit Singhal; Vanessa Mathys; Mehdi Kiass; Colette Creusy; Baptiste Delaire; El Moukhtar Aliouat; Véronique Dartois; Gilla Kaplan; Pablo Bifani
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

9.  Of creatures great and small: the advantages of farm animal models in immunology research.

Authors:  Amanda J Gibson; Tracey J Coffey; Dirk Werling
Journal:  Front Immunol       Date:  2013-05-27       Impact factor: 7.561

Review 10.  Challenges in the research and development of new human vaccines.

Authors:  T Barbosa; M Barral-Netto
Journal:  Braz J Med Biol Res       Date:  2013-02       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.